1. Home
  2.  » 
  3. Expert Content
  4.  » 
  5. Drug Product Manufacturing
  6.  » The Path to Self-Administration: Considerations for Moving from Pre-Filled Syringe to Auto-Injector

The Path to Self-Administration: Considerations for Moving from Pre-Filled Syringe to Auto-Injector

Summary: With patient care increasingly moving into outpatient facilities and even the home, auto-injectors are an increasingly viable option for enabling patients and their caregivers to self-administer therapies. However, there are a number of important considerations for pharmaceutical companies that are considering a move to auto-injector devices. In this executive summary, Catalent Biologics offers advice to pharma companies on three key areas of auto-injector device development: patient-centered design, container and device considerations, and manufacturing partner selection.

 

Click here to download the Executive Summary